THE-META-DAISIES
In a world first, metaverse rock band The Meta Daisies has released its debut single and meta-cinematic ‘Radiance’, propelling the music industry into a new virtual era. Imagine rock stars from the past being reborn, bringing their music and energy to a new generation - this is The Meta Daisies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005548/en/
The Meta Daisies is the digital offspring of The Dead Daisies - a global phenomenon comprised of legends from Deep Purple, Whitesnake and Dio. With their label and management Spitfire Music and a team of metaverse experts, the band built a strategy to bring their music to generations to come. Through The Meta Daisies, the band is building on its legacy while reimagining The Dead Daisies for Gen Z.
The ‘Radiance’ meta-cinematic was made by trailblazing games industry experts Altergaze, creators of HoverGrease and early pioneers in VR & XR. The meta-cinematic gives a glimpse into The Meta Daisies home in the metaverse - Daisyland. Here we meet Daisy, the time travelling, half-human half-supernatural, guardian of The Meta Daisies, who is on a mission to keep rock alive. Check out the meta-cinematic here .
Fans can experience a taste of Daisyland with a listening party in the Avakin Life metaverse from June 9th to June 16th. Metaverse agnostic, The Meta Daisies plan to bring their music to multiple platforms in the future, starting with Avakin Life.
“The metaverse is a new frontier for music, and what better place is there to keep the rock legacy alive?! ” David Edwards, the band’s manager, says. “The Meta Daisies is an exciting new hard-rocking band that is boldly going where no band has gone before. They are bringing everything that we love about rock to a whole new generation, and ‘Radiance’ is just the beginning! We’re really looking forward to the next step of this journey, into Daisyland and the metaverse, bringing new and exclusive music to a new audience of fans. Keep your eyes peeled for more news soon! ”
Behind this project are, David Lowy, The Dead Daisies guitarist and Australian financial magnate, and David Edwards the brains behind Spitfire Music Pty Ltd. They assembled an expert team, including Liviu Antoni of Altergaze (League of Legends, The War of The Worlds) and Dimoso (Marvel, Warner, Angry Birds). Key consultants were also partnered with, including Thomas Lee (Final Fantasy IX) and Kelly Vero (Tomb Raider, Transformers).
To find out more visit www.themetadaisies.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005548/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
1GLOBAL Empowers Revolut to Offer Mobile Plans in Poland16.12.2025 13:04:00 CET | Press release
1GLOBAL, a technology-driven global mobile communications provider, strengthens its partnership with Revolut, expanding the leading neobank’s mobile data plan offering to the Polish market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216769985/en/ 1GLOBAL strengthens its partnership with Revolut, expanding the leading neobank’s mobile data plan offering to the Polish market. By integrating 1GLOBAL’s eSIM capability into its multi-service app, Revolut’s customers in Poland who signed up to the waitlist can now enjoy bundled mobile plans that include competitively priced domestic data plans starting at zł 25 per month (approx. €6.00 per month) with unlimited calls and texts in Poland and the EU, in just a few taps. For 1GLOBAL, this expansion marks another milestone in the company’s embedded telco services strategy. The services are trusted by more than 4,000 corporate partners across a variety of industries including fi
Dompé Doses First Patients in Europe and US in Phase 3 Studyof Isocyclosporin for Atopic Keratoconjunctivitis16.12.2025 13:00:00 CET | Press release
Atopic keratoconjunctivitis(AKC) is a chronic inflammatory disease of the eye that is frequently associated with atopic conditions, and limited disease awareness often leads to delayed or missed diagnosis. Isocyclosporin is a novel, dual inhibitor oftwo critical immunepathways in ocular inflammation like AKC. Dompé, a leading biopharmaceutical company with operations in Italy and the U.S., announced the first patients have been enrolled in a Phase 3 study of Isocyclosporin for the treatment of atopic keratoconjunctivitis (AKC). Isocyclosporin is a dual inhibitor of transient receptor potential (TRP) cation channel, mucolipin subfamily, member 2 (TRPML2) and calcineurin, key regulators of immune and inflammatory response in chronic inflammatory eye diseases. The Phase 3 trial is a multicenter, randomized, double-masked study comparing isocyclosporin against vehicle control in improving ocular signs and symptoms after six weeks of treatment. “This milestone underscores Dompé’s commitment
Visa Launches Stablecoin Settlement in the United States, Marking a Breakthrough for Stablecoin Integration16.12.2025 13:00:00 CET | Press release
With more than $3.5B in annualized stablecoin settlement volume1, Visa brings USDC settlement to U.S. institutions. Visa Inc. (V) today announced the launch of USDC settlement in the United States, marking a major milestone in the company’s stablecoin settlement pilot program and strategy to modernize its settlement layer underpinning global commerce. For the first time, U.S. issuer and acquirer partners can settle with Visa in Circle’s USDC, a fully reserved, dollar-denominated stablecoin. With USDC settlement, issuers can benefit from faster funds movement over blockchains, seven‑day availability and enhanced operational resilience across weekends and holidays - without any change to the consumer card experience. Initial banking participants include Cross River Bank and Lead Bank, which have started settling with Visa in USDC over the Solana blockchain. Broader availability in the U.S. is planned through 2026. Additionally, Visa is a design partner for Arc, a new Layer 1 blockchain d
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press release
PaaS leader ensures seamless migrations and uninterrupted payment operations Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of an
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom